Planned preterm delivery and treatment of retinal neovascularization in Norrie disease

Ophthalmology. 2014 Jun;121(6):1312-3. doi: 10.1016/j.ophtha.2014.01.001. Epub 2014 Feb 14.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Blindness / congenital*
  • Blindness / diagnosis
  • Blindness / drug therapy
  • Blindness / genetics
  • DNA Mutational Analysis
  • Eye Proteins / genetics
  • Female
  • Fluorescein Angiography
  • Genetic Diseases, X-Linked
  • Humans
  • Infant
  • Infant, Newborn
  • Intravitreal Injections
  • Laser Coagulation
  • Low Density Lipoprotein Receptor-Related Protein-5 / genetics
  • Male
  • Mutation
  • Nerve Tissue Proteins / genetics
  • Nervous System Diseases / diagnosis
  • Nervous System Diseases / drug therapy*
  • Nervous System Diseases / genetics
  • Pedigree
  • Pregnancy
  • Premature Birth*
  • Retinal Degeneration
  • Retinal Hemorrhage / diagnosis
  • Retinal Hemorrhage / surgery
  • Retinal Neovascularization / diagnosis
  • Retinal Neovascularization / drug therapy*
  • Retinal Neovascularization / genetics
  • Siblings
  • Spasms, Infantile / diagnosis
  • Spasms, Infantile / drug therapy*
  • Spasms, Infantile / genetics
  • Ultrasonography, Prenatal
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Eye Proteins
  • LRP5 protein, human
  • Low Density Lipoprotein Receptor-Related Protein-5
  • NDP protein, human
  • Nerve Tissue Proteins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab

Supplementary concepts

  • Norrie disease